Brief: Betterlife Pharma - Enters Into Research Agreement With Carleton University For Td-0148A Depression Studies
08/03/2021 13:16
March 8 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE PHARMA - ENTERS INTO RESEARCH AGREEMENT WITH
CARLETON
UNIVERSITY FOR TD-0148A DEPRESSION STUDIES
Source text for Eikon: ID:nGNX8K2Z98
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units